Study Finds GLP-1RAs Were Associated With a Reduced Risk of Developing Colorectal Cancer vs Aspirin - Takeaway - MDSpire
Clinical Guidelines

Study Finds GLP-1RAs Were Associated With a Reduced Risk of Developing Colorectal Cancer vs Aspirin

Excluding skin cancers, colorectal cancer is the third most common cancer diagnosed in both men and women in the United States. According to the American Cancer Society, in 2025, about 154,270 individ...

Share

  • 1

    Colorectal cancer is the third most common cancer in the U.S.

  • 2

    154,270 expected diagnoses in

  • 3

    Low-dose aspirin has significant bleeding risks.

  • 4

    GLP-1RAs reduce cancer risk by 36% compared to aspirin.

  • 5

    Study used data from 281,656 participants.

  • 6

    Improved safety profile of GLP-1RAs shows lower acute kidney injuries.

  • 7

    Further research is encouraged for validation.

Original Source(s)

Study Finds GLP-1RAs Were Associated With a Reduced Risk of Developing Colorectal Cancer vs Aspirin

  • by Jo Cavallo

  • April 24, 2026

Related Content

AI-Driven Multiagent System for Guiding First-Line Immunotherapy for NSCLC

An artificial intelligence (AI) multiagent system demonstrated correct and complete reasoning in determining the use of immunotherapy for patients with non–small cell lung cancer (NSCLC) in the first-...

Ulrich Steidl, MD, PhD, Named Director of Montefiore Einstein Comprehensive Cancer Center

An international leader in blood cancer and stem cell research has been named Director of the Montefiore Einstein Comprehensive Cancer Center and Vice President of Cancer Medicine at Montefiore Einste...

Dietary Influence on Leukemia and Lymphoma Progression

In 2015, LH, a 66-year-old female, was diagnosed with chronic lymphocytic leukemia (CLL), Rai stage 0. Untreated, the woman’s lymphocyte count rose from 5,000/mm3 to 16,000/mm3 in 6 years (doubling ti...